We are live on ! Find out more
HF

HRT Financial Portfolio holdings

AUM $40.1B
1-Year Est. Return 58.22%
This Fund
S&P 500
This Quarter Est. Return
+2.06%
1 Year Est. Return
+58.22%
3 Year Est. Return
+133.11%
5 Year Est. Return
+158.39%
10 Year Est. Return
+582.81%
AUM
$17.8B
AUM Growth
+$1.56B
Cap. Flow
+$1.29B
Cap. Flow %
7.26%
Top 10 Hldgs %
44.67%
Holding
3,394
New
1,168
Increased
565
Reduced
380
Closed
1,233

Sector Composition

Rank Sector Weight
1 Technology 9.28%
2 Industrials 7.93%
3 Consumer Discretionary 7.91%
4 Financials 7.65%
5 Healthcare 5.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PWR icon
2926
Quanta Services
PWR
$100B
-1,381
Closed -$358K
PYXS icon
2927
Pyxis Oncology
PYXS
$238M
-139,142
Closed -$592K
QBTS icon
2928
D-Wave Quantum Inc. Common Stock
QBTS
$7.19B
-226,474
Closed -$462K
HTT
2929
High Templar Tech Ltd
HTT
$385M
-43,995
Closed -$109K
QMCO icon
2930
Quantum Corp
QMCO
$460M
-792
Closed -$9K
QNRX
2931
Quoin Pharmaceuticals
QNRX
$9.18M
-866
Closed -$28K
QSPT icon
2932
FT Vest Nasdaq-100 Buffer ETF September
QSPT
$636M
-13,521
Closed -$337K
QUBT icon
2933
Quantum Computing Inc
QUBT
$1.98B
-50,402
Closed -$49K
QUIK icon
2934
QuickLogic
QUIK
$246M
-19,570
Closed -$313K
QURE icon
2935
uniQure
QURE
$3.15B
-45,035
Closed -$234K
RACE icon
2936
Ferrari
RACE
$71.6B
-1,745
Closed -$760K
RANI icon
2937
Rani Therapeutics
RANI
$87.8M
-22,587
Closed -$70K
RARE icon
2938
Ultragenyx Pharmaceutical
RARE
$2.55B
-7,869
Closed -$367K
RAPT
2939
DELISTED
RAPT Therapeutics
RAPT
-5,109
Closed -$367K
RCL icon
2940
CALL
Royal Caribbean
RCL
$85.7B
-2,400
Closed -$333K
RCMT icon
2941
RCM Technologies
RCMT
$202M
-19,034
Closed -$406K
RDFN
2942
DELISTED
Redfin
RDFN
-110,029
Closed -$731K
REAL icon
2943
The RealReal
REAL
$1.54B
-277,987
Closed -$1.09M
REFR icon
2944
Research Frontiers
REFR
$16.3M
-13,997
Closed -$18K
REGN icon
2945
Regeneron Pharmaceuticals
REGN
$79.5B
-11,058
Closed -$10.6M
REKR icon
2946
Rekor Systems
REKR
$89M
-114,180
Closed -$261K
RELY icon
2947
Remitly
RELY
$5.46B
-33,139
Closed -$687K
REX icon
2948
REX American Resources
REX
$1.43B
-41,894
Closed -$1.23M
RGEN icon
2949
Repligen
RGEN
$9B
-1,130
Closed -$207K
RGLS
2950
DELISTED
Regulus Therapeutics
RGLS
-62,797
Closed -$180K

Similar funds

HRT Financial's Q2 2024 Portfolio in Review

As of Q2 2024, HRT Financial held 3,394 positions worth $17.8B, up 9.6% from $16.3B the previous quarter. Its ten largest holdings account for 45% of the portfolio.

HRT Financial deployed $1.29B of net new capital in Q2 2024, opening 1,168 new positions and adding to 565 existing holdings. Its largest new stake was ExxonMobil: 1,873,568 shares worth $216M.

By sector, the portfolio is most concentrated in Technology at 9.3% of assets, up from 7.5% a quarter earlier, followed by Industrials and Consumer Discretionary.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $2.3B trimmed.

  • HRT Financial's largest Q2 2024 buy was ExxonMobil: 1,873,568 shares worth $216M.
  • HRT Financial added most to Apple in Q2 2024, an estimated $185M increase.
  • HRT Financial's biggest Q2 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $2.3B.
  • HRT Financial fully exited Merck in Q2 2024, selling an estimated $203M.
  • HRT Financial's ten largest holdings make up 45% of its $17.8B portfolio in Q2 2024.
  • HRT Financial opened 1,168 new positions and closed 1,233 in Q2 2024.
  • HRT Financial's portfolio value rose 9.6% quarter-over-quarter to $17.8B.

Based on HRT Financial's 13F filing for Q2 2024, filed 12 Aug 2024.